Subsequently, we aimed to assess the efficacy of conventional chemotherapeutic agents in the treatment of MIIP-downregulated CRC when combined with the inhibition of adipocyte browning or FFA uptake in an in vivo setting. The gene discussed is MIIP; the disease is colorectal carcinoma.